AM251

From Wikipedia, the free encyclopedia
Jump to: navigation, search
AM251
AM2512d.png
AM2513d.png
Systematic (IUPAC) name
1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-
N-(1-piperidyl)pyrazole-3-carboxamide
Clinical data
Legal status
?
Identifiers
CAS number 183232-66-8
ATC code ?
PubChem CID 2125
IUPHAR ligand 744
ChemSpider 2040 YesY
ChEMBL CHEMBL285932 YesY
Chemical data
Formula C22H21Cl2IN4O 
Mol. mass 555.238 g/mol
 YesY (what is this?)  (verify)

AM-251 is an inverse agonist at the CB1 cannabinoid receptor. AM-251 is structurally very close to SR141716A (rimonabant); both are biarylpyrazole cannabinoid receptor antagonists. In AM-251 the p-chloro group attached to the phenyl substituent at C-5 of the pyrazole ring is replaced with a p-iodo group. The resulting compound exhibits slightly better binding affinity for the CB1 receptor (with a Ki value of 7.5nM) than SR141716A, which has a Ki value of 11.5nM, AM-251 is, however, about two-fold more selective for the CB1 receptor when compared to SR141716A.[1]

See also[edit]

References[edit]

  1. ^ Lan, R., Liu, Q., Fan, P., et al. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42 769-776 (1999). PubMed 10052983